EUVIMEDEUVIMED entdecken
Crossref

Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomography

Marwa Alkatheeri, Maxime Barat iD, Thibault Moyne, Anna Pellat, Anthony Dohan, Thi Thuy Linh Nguyen, Angèle Bonnin, Romain Coriat, Raphael Dautry, Alexandre Rouquette, Ugo Marchese, Philippe Soyer iD

Canadian Association of Radiologists Journal · 2026

DOI: 10.1177/08465371261426959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Association of Radiologists Journal, 2026. Verfasst von Marwa Alkatheeri und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Hôpital Cochin, AP-HP, Paris, France. Hauptthemen laut MEDLINE: Carcinoma, Adenosquamous, Tomography, X-Ray Computed, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To identify CT features that may help discriminate between pancreatic adenosquamous carcinoma (PASC) and pancreatic ductal adenocarcinoma (PDAC).

Methods

CT examinations of 42 patients with PASC were analyzed by 2 independent readers and compared to those obtained in 42 patients with PDAC. Sensitivity, specificity, and accuracy of each variable for diagnosing PASC versus PDAC were calculated. Associations between variables and PASC were examined using univariable and multivariable analyses. A CT signature was developed to distinguish PASC from PDAC.

Results

PASC presented as single (100%), oval (93%), and heterogeneously enhancing (98%) pancreatic mass with a mean largest diameter of 46.2 ± 18.5 mm, vessel encasement (69%), and segmental portal hypertension (64%), in association with hepatic metastases (52%). In univariable analysis, ring enhancement (odds ratio [OR], 25.23; P = .002), internal necrosis (OR, 9.48; P < .001), heterogeneous tumour enhancement (OR, 25.23; P = .002), and segmental portal hypertension (OR, 4.5; P = .001), were the most discriminating CT findings for the diagnosis of PASC. In multivariable analysis, internal necrosis (adjusted OR, 5.44; 95% confidence interval [CI]: 1.83-17.34; P = .003), heterogeneous tumour enhancement (adjusted OR, 8.80; 95% CI: 1.41-171.47; P = .049), and segmental portal hypertension (adjusted OR, 2.96; 95% CI: 1.02-8.97; P = .048), were independent variables strongly associated with the diagnosis of PASC. The CT signature yielded 81% sensitivity (95% CI: 66-91), 74% specificity (95% CI: 58-86), and area under the receiver operating characteristic curve of 0.840 (95% CI: 0.756-0.924) for diagnosing PASC.

Conclusion

CT examination demonstrates several features that help discriminate between PASC and PDAC. A CT signature based on 3 imaging features can help distinguish PASC from PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, AdenosquamousTomography, X-Ray ComputedPancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansDiagnosis, DifferentialFemaleMaleSensitivity and SpecificityAgedMiddle AgedRetrospective StudiesAged, 80 and overPancreas

Stichwörter der Autor:innen

X-ray computed tomographypancreaspancreatic adenosquamous carcinomapancreatic ductal carcinomapancreatic neoplasms

Autor:innen und Institutionen

  • Department of Radiology, Hôpital Cochin, AP-HP, Paris, France.
  • Faculté de Médecine, Université Paris Cité, France.
  • Department of Gastroenterology, Hôpital Cochin, AP-HP, Paris, France.
  • Department of Pathology, Hôpital Cochin, AP-HP, Paris, France.
  • Department of Hepatobiliary, Endocrine and Digestive Surgery, Hôpital Cochin, AP-HP, Paris, France.

ORCID-Profile: Maxime Barat, Philippe Soyer

Zitieren

APA

Alkatheeri, M., Barat, M., Moyne, T., Pellat, A., Dohan, A., Nguyen, T. T. L., Bonnin, A., Coriat, R., Dautry, R., Rouquette, A., Marchese, U., & Soyer, P. (2026). Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomography. Canadian Association of Radiologists Journal. https://doi.org/10.1177/08465371261426959

Vancouver

Alkatheeri M, Barat M, Moyne T, Pellat A, Dohan A, Nguyen TTL, et al. Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomography. Canadian Association of Radiologists Journal. 2026. doi:10.1177/08465371261426959

BibTeX
@article{Alkatheeri2026,
  author = {Alkatheeri, Marwa and Barat, Maxime and Moyne, Thibault and Pellat, Anna and Dohan, Anthony and Nguyen, Thi Thuy Linh and Bonnin, Angèle and Coriat, Romain and Dautry, Raphael and Rouquette, Alexandre and Marchese, Ugo and Soyer, Philippe},
  title = {Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomography},
  journal = {Canadian Association of Radiologists Journal},
  year = {2026},
  doi = {10.1177/08465371261426959}
}
Kostenlos starten →